{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:28:24Z","timestamp":1777858104232,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Animal studies suggest that the antibiotic and microglial activation inhibitor, minocycline, is likely to have a protective effect against the emergence of psychosis but evidence from human studies is lacking. The aim of this study is to examine the effects of exposure to minocycline during adolescence on the later incidence of severe mental illness (SMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A historical cohort study using electronic primary care data was conducted to assess the association between exposure to minocycline during adolescence and incidence of SMI. The Incidence Rate Ratio (IRR) was measured using Poisson regression adjusted for age, gender, time of exposure, socioeconomic deprivation status, calendar year and co-medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Early minocycline prescription ( n=13,248) did not affect the incidence of SMI compared with non-prescription of minocycline ( n=14,393), regardless of gender or whether or not the data were filtered according to a minimum exposure period (minimum period: IRR 0.96; 95% CI 0.68\u20131.36; p=0.821; no minimum period: IRR 1.08; 95% CI 0.83\u20131.42; p=0.566).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Exposure to minocycline for acne treatment during adolescence appears to have no effect on the incidence of SMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0269881117743483","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T11:52:07Z","timestamp":1512647527000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Examining the potential preventative effects of minocycline prescribed for acne on the incidence of severe mental illnesses: A historical cohort study"],"prefix":"10.1177","volume":"32","author":[{"given":"Maria","family":"Herrero-Zazo","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King\u2019s College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Brauer","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, UK"},{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Gaughran","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise M","family":"Howard","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King\u2019s College London, UK"},{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, Kent, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Barlow","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King\u2019s College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"bibr1-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.11.016"},{"key":"bibr2-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"bibr3-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2010.06.010"},{"key":"bibr4-0269881117743483","doi-asserted-by":"publisher","DOI":"10.2174\/15680266113136660165"},{"key":"bibr5-0269881117743483","volume-title":"Women and Schizophrenia","author":"Castle DJ","year":"2000"},{"key":"bibr6-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112444941"},{"key":"bibr7-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-16-9"},{"key":"bibr8-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.11.031"},{"key":"bibr9-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.10.001"},{"key":"bibr10-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00701.x"},{"key":"bibr11-0269881117743483","first-page":"CD002086","volume":"1","author":"Garner SE","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr12-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12139"},{"key":"bibr13-0269881117743483","doi-asserted-by":"publisher","DOI":"10.2174\/1872213X08666141029123524"},{"key":"bibr14-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228261"},{"key":"bibr15-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.38"},{"key":"bibr16-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082365"},{"key":"bibr17-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"bibr18-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.11.011"},{"key":"bibr19-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117724352"},{"key":"bibr20-0269881117743483","unstructured":"Joint Formulary Committee (2016) British National Formulary (Online). London: BMJ Group and Pharmaceutical Press. Available at: https:\/\/bnf.nice.org.uk\/drug\/minocycline.html#indicationsAndDoses (accessed October 2016)."},{"key":"bibr21-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01386.x"},{"key":"bibr22-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112467089"},{"key":"bibr23-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000345"},{"key":"bibr24-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.12.051"},{"key":"bibr25-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031660"},{"key":"bibr26-0269881117743483","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05117yel"},{"key":"bibr27-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.03.080"},{"key":"bibr28-0269881117743483","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04666yel"},{"key":"bibr29-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.01.011"},{"key":"bibr30-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A440"},{"key":"bibr31-0269881117743483","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v5.i2.222"},{"key":"bibr32-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.02.002"},{"key":"bibr33-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.12.002"},{"key":"bibr34-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503506"},{"key":"bibr35-0269881117743483","unstructured":"National Institute for Health and Care Excellence (2014) Clinical Knowledge Summaries: Acne vulgaris. Available at: http:\/\/cks.nice.org.uk\/acne-vulgaris (accessed 6 November 2015)."},{"key":"bibr36-0269881117743483","unstructured":"National Institute for Health and Care Excellence (2015) Key Therapeuctic Topics: Minocycline. Available at: https:\/\/www.nice.org.uk\/advice\/ktt11 (accessed October 2016)."},{"key":"bibr37-0269881117743483","unstructured":"National Institute for Health and Care Excellence (2016). Available at: https:\/\/www.nice.org.uk\/guidance (accessed October 2016)."},{"key":"bibr38-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2426"},{"key":"bibr39-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.16"},{"key":"bibr40-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.08.033"},{"key":"bibr41-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0652"},{"key":"bibr42-0269881117743483","unstructured":"Sweetman S (2016) Martindale: The Complete Drug Reference (online). London: Pharmaceutical Press. Available at: http:\/\/www.medicinescomplete.com\/ (accessed 4 October 2016)."},{"key":"bibr43-0269881117743483","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00144"},{"key":"bibr44-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1177\/2042098611435911"},{"key":"bibr45-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.11.012"},{"key":"bibr46-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037"},{"key":"bibr47-0269881117743483","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301313"},{"key":"bibr48-0269881117743483","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S64236"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881117743483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881117743483","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881117743483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:39Z","timestamp":1777507659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881117743483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1177\/0269881117743483"],"URL":"https:\/\/doi.org\/10.1177\/0269881117743483","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}